Female patients presenting with STEMI were more likely to be discharged on clopidogrel than ticagrelor or prasugrel (odds ratio (OR): 1.56, confidence interval (CI): 0.99 - 2.45), a difference that almost reached statistical significance.
← all excerpts
Disparity in the Under-Utilization of Novel P2Y12 Inhibitors in ST-Elevation Myocardial Infarction Following Percutaneous Coronary Intervention.
3
—
—
The sentences
TAILOR-PCI did not achieve significance when implementing a genotype-guided strategy for P2Y12 inhibitor choice but had an extremely low African American demographic (about 2%) [ 13 ].
Female and non-White patients were more likely to be discharged on clopidogrel than ticagrelor or prasugrel (odds ratio (OR): 1.56, confidence interval (CI): 0.99 - 2.45, and OR: 1.43, CI: 0.91 - 2.25, respectively), however, did not reach statistical significance.